Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00145704 · ClinicalTrials.gov registry record · NA
Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density
A NA study, sponsored by State University of New York - Upstate Medical University.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT00145704: Clinical Trial NA study, sponsored by State University of New York - Upstate Medical University.
NCT00145704 is a NA study that was terminated before completion, run by State University of New York - Upstate Medical University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00145704, a NA study, was terminated before completion, sponsored by State University of New York - Upstate Medical University.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this project is to evaluate the hypothesis that bisphosphonate treatment given to growth hormone deficient patients (regardless of current growth hormone replacement therapy status and without changing that status) significantly increases total body bone mineral density during an eighteen month period of treatment combined with calcium and Vitamin D when compared to calcium and Vitamin D treatment alone.
Primary Outcome
For those patients already on growth hormone replacement therapy, growth hormone will be administered as per standard of care, with standard dose ranges adjusted based upon IGF-1 monitoring. Those patients not currently receiving growth hormone replacement therapy will not be placed on therapy as a part of this study. Patients on and off growth hormone replacement therapy will be randomized in a block design to the two treatment arms to assure equal numbers in each treatment arm. The bisphosphon
Interventions
- DIETARY_SUPPLEMENT Vitamin D supplement
- DIETARY_SUPPLEMENT Calcium
- DRUG bisphosphonate therapy (risedronate)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2002-06 |
| Est. Completion | 2008-10 |
| Phase | NA |
Why NCT00145704 stopped before completion
NCT00145704 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Vitamin D supplement is the first listed.
NCT00145704 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00145704 about?
NCT00145704 is a clinical study titled "Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density". The purpose of this project is to evaluate the hypothesis that bisphosphonate treatment given to growth hormone deficient patients (regardless of current growth hormone replacement therapy status and without changing that status) significantly increases total body bone mineral density during an eigh...
What is the current status of trial NCT00145704?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2002-06. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00145704?
The interventions under investigation include: Vitamin D supplement (DIETARY_SUPPLEMENT), Calcium (DIETARY_SUPPLEMENT), bisphosphonate therapy (risedronate) (DRUG).
Who is sponsoring clinical trial NCT00145704?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00145704's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia